1800-272-662
Shopping Cart 0
countryflagAU
Login

MACH7 Technologies Ltd

Healthcare AU M7T

0.29AUD
-(-%)

Last update at 2026-03-13T03:15:00Z

Day Range

0.290.29
LowHigh

52 Week Range

0.280.69
LowHigh

Fundamentals

  • Previous Close 0.29
  • Market Cap68.15M
  • Volume144914
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.57520M
  • Revenue TTM29.70M
  • Revenue Per Share TTM0.12
  • Gross Profit TTM 4.96M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -7.95886M -9.75496M -6.65568M -6.33445M -11.63484M
Minority interest - - - - -
Net income -6.20140M -7.97032M -1.04811M -4.16785M -9.35720M
Selling general administrative 4.70M 26.96M 27.40M 23.81M 19.13M
Selling and marketing expenses 0.85M 0.82M 0.76M 0.69M 0.14M
Gross profit 8.38M -6.42021M 29.06M 26.12M 18.44M
Reconciled depreciation - 7.25M 8.68M 9.08M 9.76M
Ebit -7.97667M -22.33857M -17.16713M -6.27920M -11.32224M
Ebitda -7.06391M -15.08752M -8.48630M 2.80M -1.55991M
Depreciation and amortization 0.91M 7.25M 8.68M 9.08M 9.76M
Non operating income net other - - - - -
Operating income -8.42205M -10.08821M -7.37551M -7.03516M -10.73674M
Other operating expenses 33.17M 39.20M 6.90M 7.03M 2.16M
Interest expense 0.12M 0.06M 0.05M 0.06M 0.05M
Tax provision -1.75745M -1.78464M -5.60757M -2.16660M -2.27765M
Interest income 0.29M 0.89M 0.71M 0.70M 1.12M
Net interest income - 0.82M 0.33M -0.02828M -0.00657M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.76M -1.78464M -5.60757M -2.16660M -2.27765M
Total revenue 33.79M 17.24M 30.05M 27.08M 19.03M
Total operating expenses 7.77M 5.88M 37.43M 34.12M 29.50M
Cost of revenue 25.40M 23.66M 0.99M 0.96M 0.59M
Total other income expense net 0.46M 12.58M 10.18M 9.20M -1.15753M
Discontinued operations - - - - -
Net income from continuing ops - -7.97032M -1.04811M -4.16785M -9.35720M
Net income applicable to common shares -6.20140M -7.97032M -1.04811M -4.16785M -9.35720M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 64.21M 73.03M 82.31M 78.92M 76.97M
Intangible assets 18.34M - 31.11M 39.01M 45.76M
Earning assets - - - - -
Other current assets 1.83M 0.92M 4.16M 4.04M 3.97M
Total liab 18.63M 21.17M 22.82M 20.55M 19.05M
Total stockholder equity 45.58M 51.86M 59.48M 58.38M 57.91M
Deferred long term liab - - - - -
Other current liab 13.10M 2.46M 2.66M 2.44M 1.39M
Common stock 114.00M 116.24M 115.70M 115.30M 113.75M
Capital stock - - 115.70M 115.30M 113.75M
Retained earnings -75.01419M -71.00547M -63.52575M -63.49543M -61.32982M
Other liab - - 7.00M 9.02M 10.76M
Good will 4.28M 4.19M 4.35M 4.30M 4.10M
Other assets - - 4.95M 1.34M 1.25M
Cash 23.07M 26.18M 23.39M 25.75M 18.36M
Cash and equivalents - - 16.08M 18.32M 10.41M
Total current liabilities 14.41M 15.09M 14.83M 10.39M 7.49M
Current deferred revenue - 11.63M 11.22M 7.03M 5.58M
Net debt -21.95023M -24.90713M -22.19392M -24.42125M -17.28527M
Short term debt 0.22M 0.18M 0.21M 0.19M 0.27M
Short long term debt - - - - -
Short long term debt total 1.12M 1.27M 1.20M 1.33M 1.08M
Other stockholder equity - - -52.17134M -51.80001M -52.41642M
Property plant equipment - - 2.00M 2.07M 1.45M
Total current assets 30.28M 33.27M 34.89M 32.20M 24.40M
Long term investments - - - - -
Net tangible assets - - 24.02M 15.06M 8.05M
Short term investments - - - - 0.03M
Net receivables 5.38M 6.17M 6.71M 2.00M 2.07M
Long term debt - - - - -
Inventory - - 0.63M 0.42M -
Accounts payable 1.09M 0.82M 0.74M 0.72M 0.25M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 6.59M 6.62M 7.31M 6.58M 5.50M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 5.00M 25.02M 5.80M 0.76M 0.70M
Deferred long term asset charges - - - - -
Non current assets total 33.93M 39.76M 47.42M 46.72M 52.57M
Capital lease obligations - - 1.20M 1.33M 1.08M
Long term debt total - - 0.99M 1.14M 0.80M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.39131M -0.36101M -0.43856M -42.33336M
Change to liabilities - - 4.42M 2.97M 1.41M
Total cashflows from investing activities -1.69822M -0.39131M -0.36101M -0.43856M -42.33336M
Net borrowings - - -0.25387M -0.41011M -0.29074M
Total cash from financing activities -2.43063M -0.03208M -0.06863M 0.55M 11.21M
Change to operating activities - - -5.45350M -0.55217M -1.64018M
Net income -6.20140M -7.97032M -1.04811M -4.16785M -9.35720M
Change in cash -3.10636M 2.78M -2.35304M 24.85M 19.25M
Begin period cash flow 26.18M 23.39M 25.75M 0.90M -0.88397M
End period cash flow 23.07M 26.18M 23.39M 25.75M 18.36M
Total cash from operating activities 0.87M 3.45M -2.61205M 6.37M 1.50M
Issuance of capital stock - 0.19M 0.19M 0.96M 12.03M
Depreciation 7.24M 7.25M 1.17M 1.31M 2.47M
Other cashflows from investing activities -0.94255M -0.24404M - 0.00000M -42.23366M
Dividends paid - - - - 0.29M
Change to inventory - - 1.03M -2.42223M -0.97686M
Change to account receivables 1.08M 3.13M -4.62709M 0.08M -0.43271M
Sale purchase of stock -2.24394M - 0.19M 0.96M -0.52804M
Other cashflows from financing activities - -0.21957M -0.25387M -0.41011M -0.29074M
Change to netincome - - -4.58872M -1.03190M 1.76M
Capital expenditures 0.76M 0.15M 0.36M 0.44M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.88M 4.22M -4.62709M 0.08M -0.43271M
Stock based compensation 1.11M 1.27M 1.08M 1.70M 1.93M
Other non cash items -2.16250M -1.32289M -2.73606M 9.23M 8.38M
Free cash flow 0.11M 3.30M -2.97305M 5.94M 1.40M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
M7T
MACH7 Technologies Ltd		 - -% 0.29 - 15.38 2.29 1.62 3.04 41.71
PME
Pro Medicus Ltd		 -0.55 0.41% 133.00 59.62 73.53 58.00 36.74 58.50 75.61
AYA
ARTRYA Ltd		 -0.17 5.04% 3.20 - - 17488.26 5.98 5516.69 0.33
EIQ
Echoiq Ltd		 0.02 2.94% 0.70 - - 5046.68 25.81 4779.15 -8.2701
CGS
Cogstate Ltd		 -0.02 0.92% 2.15 23.89 19.96 6.58 5.14 4.32 13.45

Reports Covered

Stock Research & News

View All

Profile

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists' workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.

MACH7 Technologies Ltd

120 Kimball Avenue, South Burlington, VT, United States, 05403

Key Executives

Name Title Year Born
Mr. Michael Lampron CEO, MD & Director NA
Mr. Steven Parkes Global Chief Financial Officer NA
Rebecca Thompson Head of Investor Relations NA
Mr. Bob Tranchida VP of Marketing NA
Mr. David Madaffri Exec. VP NA
Ms. Veronique Morgan-Smith Company Sec. NA
Mr. David Madaffri Chief Operating Officer NA
Francoise Dixon Head of Investor Relations NA
Mr. Bob Tranchida Vice President of Marketing NA
Ms. Dyan O'Herne Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.